theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

bDMARD   

Questions discussed in this category


What is typical presentation and time course for belimumab infusion-related depression and/or hallucinations, and how do you approach management?
1 Answer available

Would you use belimumab in a breastfeeding patient with SLE who has persistent joint pain, leukopenia and elevated dsDNA despite HCQ and azathioprine?
3 Answers available

How do you manage patients who are Hepatitis B core antibody positive/surface antigen negative and starting a biologic DMARD (other than rituximab)?
1 Answer available
24068154817601


Papers discussed in this category


Arthritis Rheumatol, 2016 Jan
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Rheumatology (Oxford), 2022 Nov 02
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.

Rheumatic diseases clinics of North America, 2021 Feb 25
The Categorization of Pain in Systemic Lupus Erythematosus.

Lupus science & medicine, 2023 Jan
Molecular endotypes of type 1 and type 2 SLE.

The Lancet. Rheumatology, 2020 Dec 15
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial.

Related Topics

  • Rheumatology
  • Systemic lupus erythematosus
  • Belimumab
  • General Internal Medicine
  • Rheumatoid Arthritis
  • Hepatitis B
  • General Rheumatology
  • Infectious Disease
  • Gastroenterology
  • General Hepatology

Copyright © 2025 theMednet
All Rights Reserved.